Niamh Kearney

29PUBLICATIONS
43CO-AUTHORS
Cardiology (incl. cardiovascular diseases)AllergyAutoimmunityDisease surveillanceMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 01, 2026
Guselkumab treatment of psoriasis results in sustained reduction of systemic inflammatory biomarkers to week 48 in three phase III randomized controlled trials.

|Nov 13, 2025
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics.

Georgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova

|Aug 14, 2024
Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease.

Niamh Kearney, Xin Chen, Yingtao Bi

|Aug 30, 2023
Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa.

Andreea Petrasca, Roisin Hambly, Niamh Kearney

|May 31, 2023
Shorter time to initiation of biologic therapy in the setting of a hidradenitis suppurativa specialty clinic.

Niamh Kearney, Sarah O'Donohoe, Rosalind Hughes

|Apr 28, 2023
Metformin Treatment of Hidradenitis Suppurativa: Effect on Metabolic Parameters, Inflammation, Cardiovascular Risk Biomarkers, and Immune Mediators.

Roisin Hambly, Niamh Kearney, Rosalind Hughes

Pageof 5

Frequent Collaborators

10 joint publications

Brian Kirby

4 joint publications

Roisin Hambly

3 joint publications

N Byrne

2 joint publications

Jean M Fletcher